Graphic featuring a syringe to illustrate an HIV vaccine trial

Innovation-opedia: What is a mosaic vaccine?

As the IAS Conference on HIV Science kicks off in Mexico City, we explain how an investigational HIV vaccine from the Janssen Pharmaceutical Companies of Johnson & Johnson works—and how researchers hope to help change lives around the world with it.

Written by Johnson & Johnson

| July 22, 2019

July 22, 2019

Illustrated handwritten definition of a mosaic HIV vaccine

Illustration of a microscope with information about Janssen Vaccines & Prevention B.V. investigational HIV-1 vaccine regimen

Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_above

Illustration of the # 4 explaining how many injections would be administered for Janssen’s investigational HIV-1 vaccine.

Inset- Innovation-opedia: What Is a Mosaic Vaccine?- mosaic-vaccine-4-immunizations_below

Illustration showing location of the IAS Conference on HIV Science with details about Janssen’s new Mosaico clinical trial.

Illustrated quote by Janssen’s Maria Grazia Pau talking about the goal of creating a global HIV vaccine.

We’re committed to helping lead the fight against HIV/AIDS

Read about the many ways Johnson & Johnson is working to #makeHIVhistory.

CTA-Red ribbon HIV

HIV vaccine J&J Innovative Medicine Johnson & Johnson

More from Johnson & Johnson

Health & wellness

February 20, 2026

What is head and neck cancer?

This complex type of cancer can cause malignancies of the mouth, throat, larynx and nasal cavity. Find out how Johnson & Johnson is innovating to change the current treatment paradigm.

Innovation

February 11, 2026

5 things we now know about atrial fibrillation

More than 50 million people worldwide are affected by this common type of heart arrhythmia. Learn the facts behind this heart condition, plus one patient’s diagnosis story.

Innovation

January 29, 2026

Shockwave: Inside the development of a cutting-edge system to treat coronary artery disease

Johnson & Johnson’s Patrick Stephens explains how innovative technology using ultrasonic acoustic pressure waves has made the treatment of certain types of cardiovascular disease easier for doctors and safer for patients.